(VIANEWS) – BELSHIPS (BELCO.OL), VEIDEKKE (VEI.OL), BAM GROEP KON (BAMNB.AS) have the highest dividend yield stocks on this list.
Financial Asset | Forward Dividend Yield | Updated (EST) |
---|---|---|
BELSHIPS (BELCO.OL) | 16.26% | 2023-12-07 08:25:15 |
VEIDEKKE (VEI.OL) | 7.44% | 2023-12-08 08:44:05 |
BAM GROEP KON (BAMNB.AS) | 5.81% | 2023-12-08 08:00:47 |
GIMV (GIMB.BR) | 5.73% | 2023-12-08 08:20:02 |
CRCAM LOIRE HTE L. (CRLO.PA) | 5.31% | 2023-12-08 09:01:40 |
VRANKEN-POMMERY (VRAP.PA) | 5.1% | 2023-12-08 09:24:41 |
ALMUNDA PRO NV (AMUND.AS) | 4.92% | 2023-12-06 08:00:25 |
EUROFINS SCIENT. (ERF.PA) | 2.16% | 2023-12-08 09:02:59 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. BELSHIPS (BELCO.OL)
16.26% Foward Dividend Yield
BELSHIPS’s last close was kr18.56, 16.58% under its 52-week high of kr22.25. Intraday change was -1.47%.
Belships ASA owns and operates dry bulk ships worldwide. It operates through Own Ships, Lighthouse Naviagtion, and Ship Management segments. The company operates a fleet of 34 Supra/Ultramax bulk carriers. It also provides commercial and ship management, technical, crewing, port agency, and logistical services. The company was founded in 1918 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, BELSHIPS has a trailing twelve months EPS of kr2.82.
PE Ratio
BELSHIPS has a trailing twelve months price to earnings ratio of 6.67. Meaning, the purchaser of the share is investing kr6.67 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.41%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 50.8%, now sitting on 614.13M for the twelve trailing months.
More news about BELSHIPS.
2. VEIDEKKE (VEI.OL)
7.44% Foward Dividend Yield
VEIDEKKE’s last close was kr103.40, 15.8% below its 52-week high of kr122.80. Intraday change was 0.19%.
Veidekke ASA operates as a construction and property development company. It operates through Construction Norway, Infrastructure Norway, Construction Sweden, Infrastructure Sweden, and Denmark/Hoffmann segments. The company operates as a construction contractor; executes civil engineering and renovation projects; and produces asphalt and aggregates, as well as operates in the public road maintenance market. It is also involved in the civil engineering, recycling, and asphalting projects, as well as constructs commercial and residential buildings. Veidekke ASA was founded in 1936 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VEIDEKKE has a trailing twelve months EPS of kr8.
PE Ratio
VEIDEKKE has a trailing twelve months price to earnings ratio of 12.95. Meaning, the purchaser of the share is investing kr12.95 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.7%.
More news about VEIDEKKE.
3. BAM GROEP KON (BAMNB.AS)
5.81% Foward Dividend Yield
BAM GROEP KON’s last close was €2.55, 10.6% below its 52-week high of €2.85. Intraday change was -0.31%.
Koninklijke BAM Groep nv, together with its subsidiaries, provides products and services in the construction and property, civil engineering, and public private partnerships (PPP) sectors worldwide. The company engages in civil engineering, residential construction projects and non-residential construction activities. It is also involved in rail infrastructure and facilities management activities. In addition, the company engages in roads, education, health care, and government building construction related businesses. Koninklijke BAM Groep nv was founded in 1869 and is headquartered in Bunnik, the Netherlands.
Earnings Per Share
As for profitability, BAM GROEP KON has a trailing twelve months EPS of €0.56.
PE Ratio
BAM GROEP KON has a trailing twelve months price to earnings ratio of 4.54. Meaning, the purchaser of the share is investing €4.54 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.15%.
Yearly Top and Bottom Value
BAM GROEP KON’s stock is valued at €2.54 at 21:50 EST, way under its 52-week high of €2.85 and way higher than its 52-week low of €1.73.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 14, 2023, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 5.81%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 10.8%, now sitting on 6.26B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BAM GROEP KON’s stock is considered to be oversold (<=20).
More news about BAM GROEP KON.
4. GIMV (GIMB.BR)
5.73% Foward Dividend Yield
GIMV’s last close was €45.85, 3.78% under its 52-week high of €47.65. Intraday change was 0.22%.
Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer 2020; Connected Consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer 2020, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia. Within consumer 2020, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. It invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany with an enterprise value of up to €125 million ($144.76 million). It seeks to invest between €3 million ($3.47 million) to €30 million ($34.74 million). Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies with headquarters in Benelux, France and DACH region. It typically makes investments between €3 million ($3.47 million) to €10 million ($11.58 million) in the biopharma and medtech and between €10 million ($11.58 million) to €30 million ($34.74 million) in the health and care services. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced computation power, and components and systems for efficient use of energy, in terms of production, storage, management, use and transport sectors. It focuses on B2B products and services, based on innovation, advanced engineering, advanced manufacturing or software. It invests in companies with an enterprise value of up to €125 million ($144.76 million). It also makes flexible equity investment (equity, semi-equity, minority or majority) but always with a meaningful impact on the company and an exit trigger. It seeks to invest between €3 million ($3.47 million) to €30 million ($34.74 million). Within sustainable cities, it focuses on Products, services and infrastructure for building sustainable urban societies: Utilities and consumer goods related to energy and other (raw) materials, Waste treatment, recycling and recovery, Construction and Infrastructure, Transport and Logistics Services, and biomass, green (sustainable) chemistry, water, offshore and maritime solutions and energy efficient infrastructure. It invests through (mezzanine, equity, minority or majority) but will always strive to have a meaningful impact on the company strategy and need an exit trigger. It also invests in semiconductors, chemicals, agriculture, clean technology, electronics, water processing and purification technologies. It seeks to invest in small to medium companies with headquarters in the Benelux, France and Germany (DACH) targeting an international customer base. For fund of fund investments, it seeks to invest in Europe. It typically invests between $2.9 million and $425.439 million in companies with an enterprise value between $86.85 million and $868.55 million and sales value ranging from $6.67 million to $567.252 million. It may take a majority or a minority stake in its portfolio companies. Its investment horizon is between four and seven years. It also seeks a board seat in its portfolio companies. It invests with capital from its own balance sheet and through various funds under management. Gimv NV was founded on February 25, 1980 and is based in Antwerp, Belgium with additional offices in Paris, France; Hague, The Netherlands; Frankfurt am Main, Germany; London, United Kingdom; Prague, Czech Republic; Warsaw, Poland; and Munich, Germany.
Earnings Per Share
As for profitability, GIMV has a trailing twelve months EPS of €6.41.
PE Ratio
GIMV has a trailing twelve months price to earnings ratio of 7.17. Meaning, the purchaser of the share is investing €7.17 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.99%.
Volume
Today’s last reported volume for GIMV is 11628 which is 2.11% below its average volume of 11879.
Moving Average
GIMV’s worth is way above its 50-day moving average of €39.64 and higher than its 200-day moving average of €42.69.
Revenue Growth
Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 253.88M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jul 3, 2023, the estimated forward annual dividend rate is 2.6 and the estimated forward annual dividend yield is 5.73%.
More news about GIMV.
5. CRCAM LOIRE HTE L. (CRLO.PA)
5.31% Foward Dividend Yield
CRCAM LOIRE HTE L.’s last close was €58.00, 12.99% below its 52-week high of €66.66. Intraday change was -0.86%.
Caisse Régionale de Crédit Agricole Mutuel Loire Haute-Loire Société coopérative provides various banking products and services to individuals, professionals, farmers, business, public community and social housing, and associations in France. It offers accounts and cards; real estate loans and consumer credit; operating cycle, and company equipment and real estate financing; trade and export financing; savings products, such as life insurance, real estate investments, stock exchanges and financial investment, and retirement saving solutions; car and two-wheeler, home, personal, leisure and daily life, borrower, professional premises, professional vehicle, health, employee, activity, agricultural buildings, agricultural equipment and activity, and other insurance products; collection and payment services; cash management, business creation financing, medium-term credit, and leasing products; and treasury services. The company is based in Saint-Étienne, France. Caisse Régionale de Crédit Agricole Mutuel Loire Haute-Loire Société coopérative operates as a subsidiary of Crédit Agricole S.A.
Earnings Per Share
As for profitability, CRCAM LOIRE HTE L. has a trailing twelve months EPS of €9.22.
PE Ratio
CRCAM LOIRE HTE L. has a trailing twelve months price to earnings ratio of 6.24. Meaning, the purchaser of the share is investing €6.24 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4%.
More news about CRCAM LOIRE HTE L..
6. VRANKEN-POMMERY (VRAP.PA)
5.1% Foward Dividend Yield
VRANKEN-POMMERY’s last close was €15.85, 17.02% under its 52-week high of €19.10. Intraday change was 0.63%.
Vranken-Pommery Monopole Société Anonyme produces and sells wines and champagnes in Europe, North America, and the Asia Pacific. It offers its products under the Champagne Charles Lafitte, Champagne Demoiselle, Champagne Pommery, Champagne Heidsieck & C° Monopole, Champagne Vranken – Diamant, Champagne Germain, Sao Pedro, Rozès, and Grifo brands. Vranken-Pommery Monopole Société Anonyme was founded in 1976 and is headquartered in Reims, France.
Earnings Per Share
As for profitability, VRANKEN-POMMERY has a trailing twelve months EPS of €1.15.
PE Ratio
VRANKEN-POMMERY has a trailing twelve months price to earnings ratio of 13.87. Meaning, the purchaser of the share is investing €13.87 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.66%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 339.97M for the twelve trailing months.
Moving Average
VRANKEN-POMMERY’s worth is under its 50-day moving average of €16.40 and below its 200-day moving average of €17.59.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VRANKEN-POMMERY’s stock is considered to be oversold (<=20).
More news about VRANKEN-POMMERY.
7. ALMUNDA PRO NV (AMUND.AS)
4.92% Foward Dividend Yield
ALMUNDA PRO NV’s last close was €1.26, 21.25% below its 52-week high of €1.60. Intraday change was 8.62%.
Almunda Professionals N.V., a business and IT consultancy company, provides business services in the financial sector. It offers consultancy services in the areas of regulatory change, digital transformation, information security, and information services. The company was formerly known as Novisource N.V. and changed its name to Almunda Professionals N.V. in August 2021. Almunda Professionals N.V. was founded in 2001 and is based in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ALMUNDA PRO NV has a trailing twelve months EPS of €-0.02.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.64%.
Yearly Top and Bottom Value
ALMUNDA PRO NV’s stock is valued at €1.26 at 21:50 EST, way below its 52-week high of €1.60 and higher than its 52-week low of €1.15.
Volatility
ALMUNDA PRO NV’s last week, last month’s, and last quarter’s current intraday variation average was 1.68%, 1.08%, and 4.21%.
ALMUNDA PRO NV’s highest amplitude of average volatility was 6.85% (last week), 4.95% (last month), and 4.21% (last quarter).
Volume
Today’s last reported volume for ALMUNDA PRO NV is 700 which is 291.06% above its average volume of 179.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.3%, now sitting on 25.45M for the twelve trailing months.
More news about ALMUNDA PRO NV.
8. EUROFINS SCIENT. (ERF.PA)
2.16% Foward Dividend Yield
EUROFINS SCIENT.’s last close was €55.16, 24.06% below its 52-week high of €72.64. Intraday change was -0.33%.
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 130,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; and testing for persistent organic pollutants, dioxins and organic contaminants, pesticides, mycotoxins, allergens, and pathogens and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Earnings Per Share
As for profitability, EUROFINS SCIENT. has a trailing twelve months EPS of €2.28.
PE Ratio
EUROFINS SCIENT. has a trailing twelve months price to earnings ratio of 24.11. Meaning, the purchaser of the share is investing €24.11 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.12%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.9%, now sitting on 6.51B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUROFINS SCIENT.’s stock is considered to be oversold (<=20).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jul 4, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 2.16%.
More news about EUROFINS SCIENT..